Acutus Medical, Inc. (AFIB)
OTCMKTS: AFIB · Delayed Price · USD
0.0590
+0.0140 (31.11%)
May 17, 2024, 3:49 PM EDT - Market closed

Acutus Medical Statistics

Total Valuation

Acutus Medical has a market cap or net worth of $1.75 million. The enterprise value is $20.27 million.

Market Cap 1.75M
Enterprise Value 20.27M

Important Dates

The next estimated earnings date is Tuesday, May 21, 2024, after market close.

Earnings Date May 21, 2024
Ex-Dividend Date n/a

Share Statistics

Acutus Medical has 29.72 million shares outstanding. The number of shares has increased by 3.23% in one year.

Shares Outstanding 29.72M
Shares Change (YoY) +3.23%
Shares Change (QoQ) n/a
Owned by Insiders (%) 3.16%
Owned by Institutions (%) 23.30%
Float 23.42M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.26
Forward PS 0.07
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 3.06
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.48

Current Ratio 3.48
Quick Ratio 2.81
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -0.12

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -160.72%
Return on Capital (ROIC) n/a
Revenue Per Employee $28,783
Profits Per Employee -$291,165
Employee Count 230
Asset Turnover 0.06
Inventory Turnover 0.69

Taxes

In the past 12 months, Acutus Medical has paid $1.45 million in taxes.

Income Tax 1.45M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -93.14% in the last 52 weeks. The beta is 0.26, so Acutus Medical's price volatility has been lower than the market average.

Beta (1Y) 0.26
52-Week Price Change -93.14%
50-Day Moving Average 0.15
200-Day Moving Average 0.33
Relative Strength Index (RSI) 31.72
Average Volume (30 Days) 1,216,101

Short Selling Information

The latest short interest is 553,603, so 1.86% of the outstanding shares have been sold short.

Short Interest 553,603
Short Previous Month 845,166
Short % of Shares Out 1.86%
Short % of Float 2.36%
Short Ratio (days to cover) 0.68

Income Statement

In the last 12 months, Acutus Medical had revenue of $6.62 million and -$66.97 million in losses. Loss per share was -$0.87.

Revenue 6.62M
Gross Profit -547,000
Operating Income 5.00M
Pretax Income 2.40M
Net Income -66.97M
EBITDA -819,000
EBIT -446,000
Loss Per Share -$0.87
Full Income Statement

Balance Sheet

The company has $19.95 million in cash and $38.47 million in debt, giving a net cash position of -$18.51 million or -$0.62 per share.

Cash & Cash Equivalents 19.95M
Total Debt 38.47M
Net Cash -18.51M
Net Cash Per Share -$0.62
Equity / Book Value -4.02M
Book Value Per Share -0.14
Working Capital 24.53M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$63.53 million and capital expenditures -$92,000, giving a free cash flow of -$63.62 million.

Operating Cash Flow -63.53M
Capital Expenditures -92,000
Free Cash Flow -63.62M
FCF Per Share -$2.14
Full Cash Flow Statement

Margins

Gross margin is -8.26%, with operating and profit margins of 75.59% and -1,011.60%.

Gross Margin -8.26%
Operating Margin 75.59%
Pretax Margin 36.28%
Profit Margin -1,011.60%
EBITDA Margin -12.37%
EBIT Margin -6.74%
FCF Margin -961.09%

Dividends & Yields

Acutus Medical does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.23%
Shareholder Yield -3.23%
Earnings Yield -3,818.95%
FCF Yield -3,628.26%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Acutus Medical has an Altman Z-Score of -19.36 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -19.36
Piotroski F-Score 3